ICOS Icos

ICOS Corporation (Nasdaq:ICOS) will announce its 2005 third quarter financial results on Thursday, November 3, 2005, after the market close. At 4:30 p.m. EST, company management will host a webcast discussion of financial results and related matters, including financial guidance and future plans. Access to the discussion can be obtained as follows. LIVE Access on November 3, 2005, 4:30 p.m. EST: -- Phone (612) 332-0932; Passcode 795469. -- Webcast connection through the ICOS Web site at www.icos.com in the Investor/Events section. REPLAY Access: -- Phone replay accessible from November 3, 2005, 8:00 p.m. EST, for 24 hours at (320) 365-3844; Passcode 795469. -- Webcast replay, available through November 10, 2005, on the ICOS Web site at www.icos.com in the Investor/Events section. Additional information on ICOS, including past press releases, is also available at www.icos.com. About ICOS Corporation ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS is marketing its first product, Cialis(R) (tadalafil), for the treatment of erectile dysfunction. ICOS is working to develop treatments for serious unmet medical conditions such as pulmonary arterial hypertension, benign prostatic hyperplasia, hypertension, cancer and inflammatory diseases. The forward-looking statements contained in this press release represent ICOS' judgment as of the date of this release. ICOS undertakes no obligation to publicly update any forward-looking statements. The biotechnology and pharmaceutical businesses are risky and there can be no assurance that any particular product or product candidate will be a commercial success.